Abstract:Retinoic acid inducible-gene I (RIG-I) detects short dsRNA and stem-loop RNA species bearing a 5'-triphosphate end, and functions as one of the major sensors of RNA viruses (Myong, Cui et al., 2009, Pichlmair, Schulz et al., 2006). DDX58, which encodes the RIG-I protein has been newly identified as a susceptibility gene in psoriasis, a chronic inflammatory skin disorder affecting the skin in 1-3% of the general population (2009, Tsoi, Spain et al., 2012). Recently, interleukin (IL)-23 has been demonstrated as a key master cytokine that promotes T helper 17 (Th17) cell survival and proliferation, and targeting the IL-23p19 subunit with a monoclonal antibody results in the clinical improvement in psoriasis (Kopp, Riedl et al., 2015, Zheng, Danilenko et al., 2007). Yet what triggers IL-23 production in the skin of individuals genetically predisposed to develop psoriasis is still unclear. Here, we show that RIG-I expression is increased in the affected skin derived from psoriasis patients and from IL-23-induced mouse model of psoriasis. The activation of RIG-I by 5'ppp-dsRNA, its synthetic ligand, directly causes the production of IL-23 and promotes chronic cutaneous inflammation in mice that closely resembles human psoriasis. Repeated injections of IL-23 to the ears failed to induce IL-23 production and a full psoriasiform skin phenotype, both in germ-free and RIG-I knockout mice. Furthermore, RIG-I-mediated IL-23 production was confined to the CD11c+ myeloid dendritic cells (mDCs) via nuclear factor-kappa B (NF-κB) signaling, and stimulated RIG-I expression in an auto-regulatory feedback loop. Thus, our data suggest that the RIG-I-mediated antiviral response is pivotal for the local IL-23 production in the mDCs and for the IL-23-induced psoriasiform skin inflammation in mice, supporting the notion that dysregulation in the antiviral immune responses of hosts through the innate pattern-recognition receptors may trigger the skin inflammatory conditions in the pathophysiology of psoriasis.

RIG‐I Antiviral Signaling Drives Interleukin‐23 Production and Psoriasis‐like Skin Disease

592 RIG-I Antiviral Signaling Drives Interleukin-23 Production and Psoriasis-Like Skin Disease

SRSF1 Facilitates Cytosolic DNA-Induced Production of Type I Interferons Recognized by RIG-I

Epigenetic Regulation of IL-23 by E3 Ligase FBXW7 in Dendritic Cells is Critical for Psoriasis-like Inflammation.

Psoriasis-like skin disorder in transgenic mice expressing a RIG-I Singleton-Merten syndrome variant

A Critical Role of the IL-1β-IL-1R Signaling Pathway in Skin Inflammation and Psoriasis Pathogenesis.

Nociceptive Sensory Fibers Drive Interleukin-23 Production in a Murine Model of Psoriasis via Calcitonin Gene-Related Peptide

Rig-I−/− Mice Develop Colitis Associated with Downregulation of Gαi2

Targeting STING in dendritic cells alleviates psoriatic inflammation by suppressing IL-17A production

RNA virus receptor Rig-I monitors gut microbiota and inhibits colitis-associated colorectal cancer

Soluble IL-6R-mediated IL-6 trans-signaling activation contributes to the pathological development of psoriasis

IL-23 induces CLEC5A+ IL-17A+ neutrophils and elicit skin inflammation associated with psoriatic arthritis

Inducible nitric oxide synthase-expressing myeloid-derived suppressor cells regulated by interleukin 35 contribute to the pathogenesis of psoriasis

The RNase MCPIP3 promotes skin inflammation by orchestrating myeloid cytokine response

Retinoic acid inducible gene-I, more than a virus sensor

IL-33 Contributes to Disease Severity in Psoriasis-like Models of Mouse.

RPL22 Overexpression Promotes Psoriasis-Like Lesion by Inducing Keratinocytes Abnormal Biological Behavior

IL-17D-induced inhibition of DDX5 expression in keratinocytes amplifies IL-36R-mediated skin inflammation

RasGRP1 influences imiquimod-induced psoriatic inflammation via T-cell activation in mice

Rig-I Plays A Critical Role In Negatively Regulating Granulocytic Proliferation

Pivotal Role of Dermal IL-17-Producing Γδ T Cells in Skin Inflammation